| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.41 | 0.009 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |